By Natalie Rodriguez ( July 1, 2013, 1:53 PM EDT) -- The board of directors for Onyx Pharmaceuticals Inc., a cancer-drug maker, has rejected an approximately $10 billion takeover offer made by Amgen Inc. and is now actively shopping itself to other potential suitors, according to a Sunday statement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.